Orsobio, Inc
Clinical trials sponsored by Orsobio, Inc, explained in plain language.
-
New obesity drug TLC-6740 enters early human testing
Disease control Recruiting nowThis early-stage study tests a new drug called TLC-6740 in healthy volunteers and people with obesity, with or without type 2 diabetes. The main goals are to check safety, how the drug moves through the body, and early signs of effectiveness. Up to 564 participants will take sing…
Phase: PHASE1 • Sponsor: OrsoBio, Inc • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Healthy volunteers needed to test new drug TLC-1180 for safety
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called TLC-1180 in healthy people aged 18 to 55. The main goal is to check if it is safe and how the body handles it. About 288 volunteers will take part. This study does not aim to treat any disease.
Phase: PHASE1 • Sponsor: OrsoBio, Inc • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC